Unaudited Condensed Consolidated Statements of Stockholders’ Equity - USD ($)	Common Stock	Additional Paid in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Total
Balance at Dec. 31, 2019	$ 18,451	$ 43,338,710		$ (15,712,414)	$ 27,644,747
Balance (in Shares) at Dec. 31, 2019	18,450,992
Issuance of common stock for accrued research and development expense	$ 221	1,131,792			1,132,013
Issuance of common stock for accrued research and development expense (in Shares)	220,666
Stock-based compensation		425,844			425,844
Foreign currency translation adjustment			(20,283)		(20,283)
Net loss				(3,797,198)	(3,797,198)
Balance at Mar. 31, 2020	$ 18,672	44,896,346	(20,283)	(19,509,612)	25,385,123
Balance (in Shares) at Mar. 31, 2020	18,671,658
Stock-based compensation		295,356			295,356
Foreign currency translation adjustment			(19,208)		(19,208)
Net loss				(3,816,579)	(3,816,579)
Balance at Jun. 30, 2020	$ 18,672	45,191,702	(39,491)	(23,326,191)	21,844,692
Balance (in Shares) at Jun. 30, 2020	18,671,658
Balance at Dec. 31, 2020	$ 22,535	71,648,453	(51,538)	(34,279,648)	37,339,802
Balance (in Shares) at Dec. 31, 2020	22,534,874
Sale of common stock, net of offering costs	$ 2,140	28,021,424			28,023,564
Sale of common stock, net of offering costs (in Shares)	2,140,000
Issuance of common stock for stock option exercises	$ 245	655,008			655,253
Issuance of common stock for stock option exercises (in Shares)	244,656
Issuance of common stock for warrant exercises	$ 444	179,768			180,212
Issuance of common stock for warrant exercises (in Shares)	444,751
Stock-based compensation		1,030,415			1,030,415
Foreign currency translation adjustment			(37,958)		(37,958)
Net loss				(7,654,575)	(7,654,575)
Balance at Mar. 31, 2021	$ 25,364	101,535,068	(89,496)	(41,934,223)	59,536,713
Balance (in Shares) at Mar. 31, 2021	25,364,281
Additional offering costs related to the sale of common stock		(8,545)			(8,545)
Issuance of common stock for stock option exercises	$ 8	34,492			34,500
Issuance of common stock for stock option exercises (in Shares)	7,500
Stock-based compensation		740,535			740,535
Foreign currency translation adjustment			(27,334)		(27,334)
Net loss				(4,655,712)	(4,655,712)
Balance at Jun. 30, 2021	$ 25,372	$ 102,301,550	$ (116,830)	$ (46,589,935)	$ 55,620,157
Balance (in Shares) at Jun. 30, 2021	25,371,781